This bill proposes the repeal of RSA 126-Q, which pertains to the New Hampshire Vaccine Association (NHVA). The repeal will eliminate the NHVA's role in collecting payments from approximately 80 commercial payers and third-party administrators, which are currently used to reimburse the Department of Health and Human Services for the non-governmental share of the state's universal vaccine purchasing program for children. As a result of this repeal, the state anticipates a decrease in revenue of approximately $24 million annually, which will also correspond to a decrease in state expenditures, as provider sites will need to independently purchase and manage immunization inventories for privately-insured patients under the age of 19.

The bill does not authorize any new funding or positions, but it does indicate that the Department of Health and Human Services may incur new costs related to public health response activities and communication with providers about the changes. Specifically, the Department estimates needing $44,000 for a temporary part-time position in FY26 and additional costs of $150,000 in FY26 for vaccine purchases during public health emergencies, followed by $100,000 in subsequent years. Furthermore, the Insurance Department warns that the repeal could lead to increased healthcare costs for insurers, as they may lose access to savings currently provided by the NHVA, potentially resulting in higher insurance premiums and increased insurance premium tax revenue.